Latest & greatest articles for mammography

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on mammography or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on mammography and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for mammography

161. Risk for distant recurrence of breast cancer detected by mammography screening or other methods. Full Text available with Trip Pro

Risk for distant recurrence of breast cancer detected by mammography screening or other methods. Selection of systemic adjuvant therapies for women diagnosed as having breast cancer is based on risk estimations for cancer recurrence. In such estimations, tumors detected by mammography screening are considered to be associated with a similar risk of recurrence as tumors of similar size found by other methods.To compare the risk of recurrence and survival among women with cancerous tumors (...) detected by mammography screening compared with other methods (outside of screening).Retrospective study comparing clinical, histopathological, and biological features of cancerous tumors detected by mammography screening compared with tumors detected outside of screening. Women diagnosed as having breast cancer in 1991 or 1992 were identified from the Finnish Cancer Registry (n = 2842). The median follow-up time was 9.5 years. Cancer biological variables were analyzed from tumor tissue microarrays

2004 JAMA

162. Influence of personal characteristics of individual women on sensitivity and specificity of mammography in the Million Women Study: cohort study. Full Text available with Trip Pro

Influence of personal characteristics of individual women on sensitivity and specificity of mammography in the Million Women Study: cohort study. To examine how lifestyle, hormonal, and other factors influence the sensitivity and specificity of mammography.Women recruited into the Million Women Study completed a questionnaire about various personal factors before routine mammographic screening. A sample of 122,355 women aged 50-64 years were followed for outcome of screening and incident breast

2004 BMJ

163. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. Full Text available with Trip Pro

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. The value of regular surveillance for breast cancer in women with a genetic or familial predisposition to breast cancer is currently unproven. We compared the efficacy of magnetic resonance imaging (MRI) with that of mammography for screening in this group of high-risk women.Women who had a cumulative lifetime risk of breast cancer of 15 percent or more were screened every six months (...) with a clinical breast examination and once a year by mammography and MRI, with independent readings. The characteristics of the cancers that were detected were compared with the characteristics of those in two different age-matched control groups.We screened 1909 eligible women, including 358 carriers of germ-line mutations. Within a median follow-up period of 2.9 years, 51 tumors (44 invasive cancers, 6 ductal carcinomas in situ, and 1 lymphoma) and 1 lobular carcinoma in situ were detected. The sensitivity

2004 NEJM

164. Relationship between health status and use of screening mammography and Papanicolaou smears among women older than 70 years of age. (Abstract)

Relationship between health status and use of screening mammography and Papanicolaou smears among women older than 70 years of age. Older women whose life expectancy is less than 5 years are unlikely to benefit from screening mammography or Papanicolaou (Pap) smears. Since life expectancy is better predicted by health status than by age alone, guidelines recommend considering an older woman's general health when making screening decisions.To determine whether screening mammography and Pap (...) mammography within the previous 2 years and a screening Pap smear within 3 years.Seventy-eight percent of women reported recent screening mammography, and 77% reported a recent Pap smear. Screening rates decreased with advancing age. However, within each age group, the percentage of women reporting screening did not significantly decrease with worsening health status (P > 0.1 for all comparisons). More than half of women 80 years of age or older in the worst health quartile reported recent screening

2004 Annals of Internal Medicine

165. Effect of breast augmentation on the accuracy of mammography and cancer characteristics. Full Text available with Trip Pro

Effect of breast augmentation on the accuracy of mammography and cancer characteristics. Breast augmentation is not associated with an increased risk of breast cancer; however, implants may interfere with the detection of breast cancer thereby delaying cancer diagnosis in women with augmentation.To determine whether mammography accuracy and tumor characteristics are different for women with and without augmentation.A prospective cohort of 137 women with augmentation and 685 women without (...) augmentation diagnosed with breast cancer between January 1, 1995, and October 15, 2002, matched (1:5) by age, race/ethnicity, previous mammography screening, and mammography registry, and 10 533 women with augmentation and 974 915 women without augmentation and without breast cancer among 7 mammography registries in Denver, Colo; Lebanon, NH; Albuquerque, NM; Chapel Hill, NC; San Francisco, Calif; Seattle, Wash; and Burlington, Vt.Comparison between women with and without augmentation of mammography

2004 JAMA

166. A cost-effectiveness comparison of three tailored interventions to increase mammography screening

A cost-effectiveness comparison of three tailored interventions to increase mammography screening Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2004 NHS Economic Evaluation Database.

167. Cost-effectiveness of a tailored intervention to increase screening in HMO women overdue for Pap test and mammography services

Cost-effectiveness of a tailored intervention to increase screening in HMO women overdue for Pap test and mammography services Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2004 NHS Economic Evaluation Database.

168. Computer aided detection systems in mammography

Computer aided detection systems in mammography Computer aided detection systems in mammography: a breast cancer detection tool for women attending screening and/or diagnostic mammography services. Computer aided detection systems in mammography: a breast cancer detection tool for women attending screening and/or diagnostic mammography services. Bywood P, Newton S, Merlin T, Braunack-Mayer A, Hiller J E Record Status This is a bibliographic record of a published health technology assessment (...) from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Bywood P, Newton S, Merlin T, Braunack-Mayer A, Hiller J E. Computer aided detection systems in mammography: a breast cancer detection tool for women attending screening and/or diagnostic mammography services. 2004 Authors' objectives

This Horizon Scanning Report is intended for the use of health planners and policy makers. It provides an assessment of the current state

2004 Health Technology Assessment (HTA) Database.

169. Comparison of screening mammography in the United States and the United kingdom. Full Text available with Trip Pro

Comparison of screening mammography in the United States and the United kingdom. Screening mammography differs between the United States and the United Kingdom; a direct comparison may suggest methods to improve the practice.To compare screening mammography performance between the United States and the United Kingdom among similar-aged women.Women aged 50 years or older were identified who underwent 5.5 million mammograms from January 1, 1996, to December 31, 1999, within 3 large-scale (...) mammography registries or screening programs: the Breast Cancer Surveillance Consortium (BCSC, n = 978 591) and National Breast and Cervical Cancer Early Detection Program (NBCCEDP, n = 613 388) in the United States; and the National Health Service Breast Screening Program (NHSBSP, n = 3.94 million) in the United Kingdom. A total of 27 612 women were diagnosed with breast cancer (invasive or ductal carcinoma in situ) within 12 months of screening among the 3 groups.Recall rates (recommendation for further

2003 JAMA

170. Evaluation of abnormal mammography results and palpable breast abnormalities. (Abstract)

Evaluation of abnormal mammography results and palpable breast abnormalities. Because approximately 1 in 10 women with a breast lump or abnormal mammography result will have breast cancer, a series of decisions must be taken by a primary care practitioner to exclude or establish a diagnosis of breast cancer among these women.To determine the most accurate and least invasive means to evaluate an abnormal mammography result and a palpable breast abnormality.MEDLINE search (January 1966 to March (...) 2003) for articles and reviews describing the accuracy of clinical examination, biopsy procedures, and radiographic examination for patients with abnormal mammography results or palpable breast abnormalities.The authors reviewed abstracts and selected articles that provided relevant primary data. Studies were included if 1) mammography, fine-needle aspiration biopsy, or core-needle biopsy was performed before a definitive diagnosis was obtained; 2) the study sample included 100 or more women; and 3

2003 Annals of Internal Medicine

171. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. (Abstract)

Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. More than a decade ago, a mammography screening programme for women aged 50-69 years was initiated in the Netherlands. Our aim was to assess the effect of this programme on breast-cancer mortality rates.We examined data for 27948 women who died of breast-cancer aged 55-74 years between 1980 and 1999 (30560 cases until 2001). We grouped individuals into 93 (...) in mortality trends arose at around year 0. Adjuvant systemic therapy is unlikely to be the cause of this turning point, since the mortality rates continued to rise up to 1 year after implementation in municipalities where screening began after 1995.Routine mammography screening can reduce breast-cancer mortality rates in women aged 55-74 years.

2003 Lancet

172. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. (Abstract)

Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. The long term effect of mammographic service screening is not well established. We aimed to assess the long-term effect of mammographic screening on death from breast cancer, taking into account potential biases from self-selection, changes in breast cancer incidence, and classification of cause of death.We compared deaths from breast cancer diagnosed in the 20 (...) ) but not in unscreened women (p=0.2). In both 40-69-year and 40-49-year age-groups, reductions in deaths from all cancers and from all-causes in women with breast cancer were consistent with these results.Taking account of potential biases, changes in clinical practice and changes in the incidence of breast cancer, mammography screening is contributing to substantial reductions in breast cancer mortality in these two Swedish counties.

2003 Lancet

173. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. (Abstract)

Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. The relationships among breast density, age, and use of hormone replacement therapy (HRT) in breast cancer detection have not been fully evaluated.To determine how breast density, age, and use of HRT individually and in combination affect the accuracy of screening mammography.Prospective cohort study.7 population-based mammography registries in North Carolina (...) are important predictors of the accuracy of screening mammography. Although HRT use is not an independent predictor of accuracy, it probably affects accuracy by increasing breast density.

2003 Annals of Internal Medicine

174. The cost effectiveness of 5 interventions to increase mammography adherence in a managed care population

The cost effectiveness of 5 interventions to increase mammography adherence in a managed care population The cost effectiveness of 5 interventions to increase mammography adherence in a managed care population The cost effectiveness of 5 interventions to increase mammography adherence in a managed care population Saywell R M, Champion V L, Zollinger T W, Maraj M, Skinner C S, Zoppi K A, Muegge C M Record Status This is a critical abstract of an economic evaluation that meets the criteria (...) for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Five strategies to improve mammography adherence were examined. These were: telephone counselling, in-person counselling, physician reminder letter, telephone counselling plus physician reminder letter, and in-person counselling plus physician reminder letter. Type of intervention

2003 NHS Economic Evaluation Database.

175. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. Full Text available with Trip Pro

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. The Women's Health Initiative trial of combined estrogen plus progestin was stopped early when overall health risks, including invasive breast cancer, exceeded benefits. Outstanding issues not previously addressed include characteristics of breast cancers observed among women using hormones and whether diagnosis may be influenced by hormone (...) effects on mammography.To determine the relationship among estrogen plus progestin use, breast cancer characteristics, and mammography recommendations.Following a comprehensive breast cancer risk assessment, 16 608 postmenopausal women aged 50 to 79 years with an intact uterus were randomly assigned to receive combined conjugated equine estrogens (0.625 mg/d) plus medroxyprogesterone acetate (2.5 mg/d) or placebo from 1993 to 1998 at 40 clinical centers. Screening mammography and clinical breast

2003 JAMA Controlled trial quality: predicted high

176. Regular mammography use is associated with elimination of age-related disparities in size and stage of breast cancer at diagnosis. (Abstract)

Regular mammography use is associated with elimination of age-related disparities in size and stage of breast cancer at diagnosis. There is little consensus about recommending mammography for women 75 years of age and older. These women have mammography less frequently and are more likely to receive a diagnosis of advanced breast cancer.To examine the relationship between use of screening mammography and size and stage of cancer at diagnosis in older women.Retrospective cohort study.Tumor (...) mammography than younger women (69 to 74 years of age). The association between increased mammography use and smaller tumor size and stage was significantly greater in older women than in younger women (P = 0.010 for stage; P = 0.001 for size). The percentage of regular mammography users who received a diagnosis of high-stage disease (28% vs. 26%; P > 0.2) and the mean size of the tumors (15.0 mm vs. 15.1 mm; P > 0.2) did not significantly differ between younger and older women, respectively

2002 Annals of Internal Medicine

177. News media coverage of screening mammography for women in their 40s and tamoxifen for primary prevention of breast cancer. (Abstract)

News media coverage of screening mammography for women in their 40s and tamoxifen for primary prevention of breast cancer. In the late 1990s, 3 events pertaining to breast cancer prevention received considerable attention in the US news media: a National Institutes of Health (NIH) consensus panel recommended against routine screening mammography for women in their 40s (January 1997), the National Cancer Institute (NCI) subsequently reversed the recommendation (March 1997), and an NCI-sponsored (...) ), and none left the impression that women should definitely take the drug (24% suggested they probably should). Sixty-five percent of these stories suggested that women faced a genuine choice and would have to weigh the risks and benefits themselves.Most news stories favored routine use of screening mammography and urged caution about using tamoxifen. Almost all noted the potential harms of each preventive strategy; however, the negative aspects of tamoxifen received greater emphasis. Whereas taking

2002 JAMA

178. Will screening mammography in the East do more harm than good?

Will screening mammography in the East do more harm than good? Will screening mammography in the East do more harm than good? Will screening mammography in the East do more harm than good? Leung G M, Lam T H, Thach T Q, Hedley A J Authors' objectives To evaluate the effects of white, population-based mammographic screening when applied to a low-risk Chinese population. Searching MEDLINE (January 1966 to October 2000) and the Cochrane Library were searched for potentially relevant studies (...) ; the search terms were reported. To identify additional trials, bibliographies of systematic reviews and clinical practice guidelines were scanned and experts were consulted. Only studies published in the English language were eligible for inclusion; abstracts were excluded. Study selection Study designs of evaluations included in the review Randomised controlled trials (RCTs) were eligible for inclusion in the review. Specific interventions included in the review Studies of population-based mammography

2002 DARE.

179. The effectiveness of interventions to promote mammography among women with historically lower rates of screening.

The effectiveness of interventions to promote mammography among women with historically lower rates of screening. The effectiveness of interventions to promote mammography among women with historically lower rates of screening The effectiveness of interventions to promote mammography among women with historically lower rates of screening Legler J, Meissner HI, Coyne C, Breen N, Chollette V, Rimer B K Authors' objectives To describe mammography intervention research efforts in diverse (...) populations; to determine which intervention characteristics explain variation in intervention effectiveness; and to assess the effectiveness of particular types of interventions and this benefit for specific populations of women with historically lower use of mammography (older women, women with low incomes and non-Caucasian women). Searching A 'parent' database of articles that described screening mammography interventions (see Other Publications of Related Interest no.2) was established from initial

2002 DARE.

180. Surveillance mammography after treatment of primary breast cancer: a systematic review

Surveillance mammography after treatment of primary breast cancer: a systematic review Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2002 DARE.